Julien Péron (Julien Peron)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Clinical Practice

Prognostic Factors

Ejection Fraction

Renal Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Statistics in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pauline Corbaux, Gilles Freyer, Olivier Glehen, Benoit You, Naoual Bakrin, Audrey Gelot, David Dayde, Christophe Sajous, Max Piffoux, Julien Péron, Gaelle Lescuyer, Léa Payen, Vahan Kepenekian
Intraperitoneal Nivolumab After Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Pauline Corbaux, Gilles Freyer, Olivier Glehen, Benoit You, Naoual Bakrin, Audrey Gelot, David Dayde, Christophe Sajous, Max Piffoux, Julien Péron, Gaelle Lescuyer, Léa Payen, Vahan Kepenekian
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Joris Giai, Julien Péron, Matthieu Roustit, Jean-Luc Cracowski, Pascal Roy, Brice Maxime Hugues Ozenne, Marc Buyse, Delphine Maucort-Boulch
Individualized Net Benefit estimation and meta-analysis using generalized pairwise comparisons in N-of-1 trials. Statistics in medicine (2023)
Laetitia Collet, Julien Péron, Frédérique Penault-Llorca, Pascal Pujol, Jonathan Lopez, Gilles Freyer, Benoît You
PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers. Cancers 14 (3) (2022)
Xavier Rousset, Denis Maillet, Emmanuel Grolleau, David Barthelemy, Sara Calattini, Marie Brevet, Julie Balandier, Margaux Raffin, Florence Geiguer, Jessica Garcia, Myriam Decaussin-Petrucci, Julien Péron, Nazim Benzerdjeb, Sébastien Couraud, Jean Viallet, Léa Payen
Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept. Cancers 14 (17) (2022)
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 11 (1) (2022)
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 11 (1) (2022)
Félix Pham, Samy Belkaid, Denis Maillet, Cyrille B Confavreux, Stéphane Dalle, Julien Péron
Impact of Bone Metastases on Patients with Renal Cell Carcinoma or Melanoma Treated with Combotherapy Ipilimumab Plus Nivolumab. Biomedicines 10 (11) (2022)
Vahan Kepenekian, Amaniel Kefleyesus, David Keskin, Nazim Benzerdjeb, Isabelle Bonnefoy, Laurent Villeneuve, Omar Alhadeedi, Abeer Al-Otaibi, Alexandre Galan, Olivier Glehen, Julien Péron, Pascal Rousset
Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival. Cancers 14 (18) (2022)
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 11 (1) (2022)
Denis Maillet, Nathalie Allioli, Julien Péron, Adriana Plesa, Myriam Decaussin-Petrucci, Sophie Tartas, Christophe Sajous, Alain Ruffion, Sébastien Crouzet, Gilles Freyer, Virginie Vlaeminck-Guillem
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers 13 (23) (2021)
Ambroise Lauby, Olivier Colomban, Pauline Corbaux, Julien Péron, Lilian Van Wagensveld, Witold Gertych, Naoual Bakrin, Pierre Descargues, Jonathan Lopez, Vahan Kepenekian, Olivier Glehen, Charles Andre Philip, Mojgan Devouassoux-Shisheboran, Michel Tod, Gilles Freyer, Benoit You
The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review. Cancers 14 (1) (2021)
Julien Péron, Thibault Reverdy, Colette Smentek, Marion Cortet, Benoît You, Gilles Freyer
Methods and Designs of Modern Breast Cancer Confirmatory Trials. Cancers 13 (11) (2021)
Julien Péron, Tristan Dagonneau, Anne Conrad, Fanny Pineau, Sara Calattini, Gilles Freyer, David Perol, Christophe Sajous, Maël Heiblig
COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study. Cancers 13 (21) (2021)
Charline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle, Pauline Corbaux, Amélie Boespflug, Michaël Duruisseaux, Lize Kiakouama-Maleka, Thibault Reverdy, Madeleine Maugeais, Gulsum Sahin, Denis Maillet, Julien Péron
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes. Cancers 13 (10) (2021)
Romain Varnier, Christophe Sajous, Solène de Talhouet, Colette Smentek, Julien Péron, Benoît You, Thibault Reverdy, Gilles Freyer
Using Breast Cancer Gene Expression Signatures in Clinical Practice: Unsolved Issues, Ongoing Trials and Future Perspectives. Cancers 13 (19) (2021)
Joris Giai, Delphine Maucort-Boulch, Brice Ozenne, Jean-Christophe Chiêm, Marc Buyse, Julien Péron
Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study. Statistics in medicine 40 (3) (2020)
Patrick Arnaud-Coffin, Denis Maillet, Hui K Gan, Jean-Jacques Stelmes, Benoit You, Stephane Dalle, Julien Péron
A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors. International journal of cancer 145 (3) (2019)
Olivier Colomban, Michel Tod, Alexandra Leary, Isabelle Ray-Coquard, Alain Lortholary, Anne Claire Hardy-Bessard, Jacobus Pfisterer, Andreas du Bois, Christian Kurzeder, Alexander Burges, Julien Péron, Gilles Freyer, Benoit You
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (17) (2019)